Gene-edited stem cells help five blood disorder patients stop transfusions in clinical trial
Stem cell transplantation could be a rapid and effective way to restore hemoglobin production in individuals with the blood disorder β-thalassaemia. The treatment, presented in a phase 1 clinical trial, could reduce dependence on blood transfusions in some individuals with the disease in the future, although further trials are needed to confirm these findings.
Original Source
Read the full article at Medicalxpress →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.